罗氏诊断印度公司在 cobas h 232 系统上推出了一种针对有心力衰竭风险的糖尿病患者的即时诊断 NT-proBNP 检测。 Roche Diagnostics India introduces a point-of-care NT-proBNP test for diabetes patients at risk of heart failure on the cobas h 232 system.

罗氏诊断印度公司针对有心力衰竭和心血管疾病风险的糖尿病患者推出了即时诊断 NT-proBNP 检测。 Roche Diagnostics India introduces a point-of-care NT-proBNP test for diabetes patients at risk of heart failure and cardiovascular diseases. 该测试可在 cobas h 232 系统上进行，能够更快、更有效地诊断和管理 2 型糖尿病患者的心力衰竭。 The test, available on the cobas h 232 system, enables faster and more efficient diagnosis and management of heart failure in type 2 diabetes patients. 该项目旨在通过使检测更接近诊所来彻底改变患者护理，特别是在印度等糖尿病患病率很高的发展中国家。 The launch aims to revolutionise patient care by bringing testing closer to clinics, particularly in developing countries like India, where diabetes prevalence is high.